Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 8
1980 32
1981 92
1982 123
1983 194
1984 245
1985 257
1986 302
1987 295
1988 289
1989 343
1990 281
1991 274
1992 274
1993 281
1994 287
1995 261
1996 257
1997 223
1998 262
1999 231
2000 186
2001 203
2002 173
2003 141
2004 118
2005 142
2006 151
2007 141
2008 108
2009 103
2010 112
2011 109
2012 120
2013 105
2014 125
2015 92
2016 105
2017 93
2018 95
2019 95
2020 109
2021 128
2022 90
2023 80
2024 63
2025 62
2026 39

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7,594 results

Results by year

Filters applied: . Clear all
Page 1
Ranitidine hydrochloride.
Gaginella TS, Bauman JH. Gaginella TS, et al. Drug Intell Clin Pharm. 1983 Dec;17(12):873-85. doi: 10.1177/106002808301701201. Drug Intell Clin Pharm. 1983. PMID: 6317325 Review.
Ranitidine is four to ten times more potent than cimetidine on a molar basis in inhibiting stimulated gastric acid secretion. Clinical studies have demonstrated that ranitidine is as effective as cimetidine and is similarly well tolerated. Based on available literat …
Ranitidine is four to ten times more potent than cimetidine on a molar basis in inhibiting stimulated gastric acid secretion. Clinica …
Ranitidine: a new H2-receptor antagonist.
Zeldis JB, Friedman LS, Isselbacher KJ. Zeldis JB, et al. N Engl J Med. 1983 Dec 1;309(22):1368-73. doi: 10.1056/NEJM198312013092206. N Engl J Med. 1983. PMID: 6314139 Review. No abstract available.
Clinical pharmacokinetics of ranitidine.
Roberts CJ. Roberts CJ. Clin Pharmacokinet. 1984 May-Jun;9(3):211-21. doi: 10.2165/00003088-198409030-00003. Clin Pharmacokinet. 1984. PMID: 6329583 Review.
Ranitidine penetrates very poorly into the cerebrospinal fluid but is concentrated into breast milk. ...Food has no effect on the kinetics of ranitidine but concurrent administration of antacids reduces its absorption. Renal disease causes an increase in ranitidi …
Ranitidine penetrates very poorly into the cerebrospinal fluid but is concentrated into breast milk. ...Food has no effect on the kin …
Ranitidine.
Strum WB. Strum WB. JAMA. 1983 Oct 14;250(14):1894-6. JAMA. 1983. PMID: 6312110 Clinical Trial.
Ranitidine is an H2-receptor antagonist that was released recently for use in the treatment of acute duodenal ulcer disease, Zollinger-Ellison syndrome, and systemic mastocytosis with gastric hypersecretion. The pharmacokinetics, efficacy, adverse effects, and clinical uti …
Ranitidine is an H2-receptor antagonist that was released recently for use in the treatment of acute duodenal ulcer disease, Zollinge …
N-nitrosodimethylamine (NDMA) contamination of ranitidine products: A review of recent findings.
Aldawsari FS, Alshehry YM, Alghamdi TS. Aldawsari FS, et al. J Food Drug Anal. 2021 Mar 15;29(1):39-45. doi: 10.38212/2224-6614.1133. J Food Drug Anal. 2021. PMID: 35696227 Free PMC article. Review.
Ranitidine is a medication that has been used to alleviate heartburn and other disorders for over 40 years. Following reports of N-nitrosodimethylamine (NDMA) contamination in ranitidine products, there have been many recalls and registration suspensions. Here, we r …
Ranitidine is a medication that has been used to alleviate heartburn and other disorders for over 40 years. Following reports of N-ni …
Ranitidine bismuth citrate in the treatment of Helicobacter pylori infection and duodenal ulcer.
Vondracek TG. Vondracek TG. Ann Pharmacother. 1998 Jun;32(6):672-9. doi: 10.1345/aph.17247. Ann Pharmacother. 1998. PMID: 9640487 Review.
OBJECTIVE: To review the clinical pharmacology of ranitidine bismuth citrate in the treatment of Helicobacter pylori (HP) infection and duodenal ulcer. ...It uses the acid-suppressive actions of ranitidine and the antimicrobial and mucosal protective effects of bism …
OBJECTIVE: To review the clinical pharmacology of ranitidine bismuth citrate in the treatment of Helicobacter pylori (HP) infection a …
Is ranitidine therapy sufficient for healing peptic ulcers associated with non-steroidal anti-inflammatory drug use?
Yeomans ND, Svedberg LE, Naesdal J. Yeomans ND, et al. Int J Clin Pract. 2006 Nov;60(11):1401-7. doi: 10.1111/j.1742-1241.2006.01147.x. Int J Clin Pract. 2006. PMID: 17073837 Free PMC article. Review.
The ulcer healing rate with sucralfate was similar to that of ranitidine. However, proton pump inhibitor (PPI) therapy was associated with significantly greater rates of both GU and DU healing than ranitidine; 8-week GU rates were 92% and 88% with esomeprazole 40 mg …
The ulcer healing rate with sucralfate was similar to that of ranitidine. However, proton pump inhibitor (PPI) therapy was associated …
Ranitidine. An updated review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in peptic ulcer disease and other allied diseases.
Grant SM, Langtry HD, Brogden RN. Grant SM, et al. Drugs. 1989 Jun;37(6):801-70. doi: 10.2165/00003495-198937060-00003. Drugs. 1989. PMID: 2667937 Review.
Similar dosages of ranitidine have been shown to relieve the symptoms of reflux oesophagitis and heal or prevent gastrointestinal damage caused by ulcerogenic drugs. Ranitidine 150mg orally at night maintains ulcer healing in the long term. Ranitidine has als …
Similar dosages of ranitidine have been shown to relieve the symptoms of reflux oesophagitis and heal or prevent gastrointestinal dam …
Medicine and Media: The Ranitidine Debate.
Wagner JA, Colombo JM. Wagner JA, et al. Clin Transl Sci. 2020 Jul;13(4):649-651. doi: 10.1111/cts.12753. Epub 2020 Feb 27. Clin Transl Sci. 2020. PMID: 32107850 Free PMC article.
Ranitidine has been the topic of recent media reports. Current findings, confirmed by the US Food and Drug Administration, indicate that some ranitidine products contain a substance that may be carcinogenic. ...This article comments on what is currently known about …
Ranitidine has been the topic of recent media reports. Current findings, confirmed by the US Food and Drug Administration, indicate t …
Comparison of famotidine with cimetidine and ranitidine.
Berardi RR, Tankanow RM, Nostrant TT. Berardi RR, et al. Clin Pharm. 1988 Apr;7(4):271-84. Clin Pharm. 1988. PMID: 2896559 Review.
The pharmacodynamic, therapeutic, and toxicologic properties of famotidine are evaluated and compared with those of cimetidine and ranitidine. Famotidine, an H2-receptor antagonist with a thiazole nucleus, is approximately 7.5 times more potent than ranitidine and 2 …
The pharmacodynamic, therapeutic, and toxicologic properties of famotidine are evaluated and compared with those of cimetidine and raniti …
7,594 results